The epidermal growth factor receptor (EGFR) belongs to the ErbB family of receptor tyrosine kinases. EGFR activation upon binding of ligands (such as EGF and TGF-α) results in cell signaling cascades that promote cell proliferation, survival and apoptosis inhibition. As reported for many solid tumors, EGFR overactivation is associated with tumor development and progression, resistance to cancer therapies and poor prognosis. Therefore, inhibition of EGFR function is a rational cancer therapy approach. We have shown previously that 280 nm UV illumination of two cancer cell lines overexpressing EGFR could prevent phosphorylation of EGFR and of its downstream signalling molecules despite the presence of EGF. Our earlier studies demonstrated that UV illumination of aromatic residues in proteins leads to the disruption of nearby disulphide bridges. Since human EGFR is rich in disulphide bridges and aromatic residues, it is likely that structural changes can be induced upon UV excitation of its pool of aromatic residues (Trp, Tyr and Phe). Such changes may impair the correct binding of ligands to EGFR which will halt the process of tumor growth. In this paper we report structural changes induced by UV light on the extracellular domain of human EGFR. Steady state fluorescence spectroscopy and binding immunoassays were carried out. Our goal is to gain insight at the protein structure level that explains the way the new photonic cancer therapy works. This technology can be applicable to the treatment of various forms of cancer, alone or in combination with other therapies to improve treatment outcome.
INTRODUCTION
The Epidermal Growth Factor Receptor (EGFR or HER1/Erb-B1), a member of the ErbB family of receptor tyrosine kinases (RTKs), is frequently altered due to mutations affecting EGFR expression or activity in many types of human malignancy, such as in non-small-cell lung cancer (NSCLC). This has been directly correlated with tumor development and progression, resistance to various cancer treatment approaches and poor prognosis [1] . EGFR is a transmembrane glycoprotein composed of 1186 amino acids that is divided into an amino-terminal 622 amino acid extracellular ligandbinding domain, a transmembrane region and an intracellular tyrosine kinase domain with a regulatory COOH-terminal segment [2, 3] . The prevailing model for activation of human EGFR supports that binding of ligands such as epidermal growth factor (EGF) and transforming growth factor alpha (TGF-α) to the extracellular domain of EGFR induces receptor dimerization. Receptor dimerization results in conformational changes that bring the two cytoplasmatic domains closer, resulting in autophosphorylation of specific tyrosine residues in the intracellular tyrosine kinase domain. This autophosphorylation results in the activation of EGFR intrinsic kinase activity, which in turn results in the activation of cell signaling cascades that promote cell proliferation, survival and apoptosis inhibition [3] [4] [5] .
The recognition of the role of EGFR in oncogenesis has led to the development of EGFR-targeted agents to inhibit EGFR activity [6, 7] . Those include the EGFR tyrosine kinase inhibitors (EGFR-TKIs) gefitinib and erlotinib, which compete with ATP at the intracellular tyrosine kinase domain [8, 9] , and monoclonal antibodies (mAbs) such as cetuximab, matuzumab and nimotuzumab that act by preventing ligand-binding or receptor dimerization [10] [11] [12] ). Previously, we have also shown that in A431 cells (human epidermoid carcinoma cells) and Cal-39 cells (derived from human vulva squamous cell carcinoma cells) relatively low intensity UV light (0.273 mW 200fs femtosecond pulses at 280 nm diffused onto a petri dish area) could prevent phosphorylation of EGFR and of its downstream signalling molecules despite the presence of EGF [13] . This may lead to an important new modality in the treatment of various cancers where this protein is altered. In order to achieve such as goal, it is however essential to understand how UV light can affect the structure of EGFR.
For several years, there has been significant interest on the effects of UV light excitation of proteins [14] [15] [16] [17] [18] [19] . In proteins, the main targets of UV light induced photo-degradation are the peptide backbone, tryptophan (Trp), tyrosine (Tyr), phenylalanine, and cystine (name given to a dimer of two cysteine covalently linked by a disulfide (SS) bridge). Excitation to higher energy states is followed by relaxation to ground state (e.g. fluorescence, phosphorescence) or to excited state photochemical or photophysical processes, such as photoionization [20] .
Flash photolysis studies have revealed two non-radiative relaxation channels from the singlet excited state of Trp [21] Another aromatic residue with non-negligible absorption in the near-UV region is tyrosine (Tyr-OH). Photoexcited tyrosine can fluoresce, decay non-radiatively, or undergo intersystem crossing to the triplet state, from which most of the photochemistry proceeds. Alternatively, at neutral pH, tyrosine can be photoionized through a biphotonic process that involves absorption of a second photon from the triplet state (scheme 6). This results in a solvated electron (e -aq ) and a radical cation (Tyr-OH •+ ) that will rapidly deprotonate to create the neutral radical (Tyr-OH
• , scheme 7). Photoionization of tyrosinate at high pH is monophotonic and results in a neutral radical (Tyr-O • ) and a solvated electron (e -aq ) (scheme 8).
The triplet state tyrosine is rapidly quenched by molecular oxygen or nearby residues like tryptophan or disulphide bridges [21] : 
An important photochemical mechanism in proteins involves reduction of SS bridges upon UV excitation of Trp and Tyr side chains [14] [15] [16] 19] . As shown above, UV excitation of tryptophan or tyrosine can result in photoionization and generation of solvated electrons [15, 16, [20] [21] [22] . The solvated electrons can subsequently undergo fast geminate recombination with their parent molecule, or they can be captured by electrophilic species like molecular oxygen, H 3 O + (at low pH), and cystines as summarized below:
In the case where the electron is captured by the cystine, the result can also be the breakage of the SS bridge:
Reduction of SS upon UV excitation of aromatic residues has been shown for proteins such as cutinase and lysozyme [14, 15, 23] , bovine serum albumin [24, 25] prostate specific antigen [26] , antibody Fab fragments [27] , insulin [17] and alpha-lactalbumin [18] . Figure 1 . The spatial proximity between aromatic residues and disulphide (SS) bridges has been conserved throughout molecular evolution. Trp is the preferred spatial neighbor of SS bridges [26] . UV excitation of the side chain of aromatic residues leads to electron ejection. The electron can then be captured by disulphide bridges, leading to their dissociation.
Bioinformatics studies show that the extracellular domain of EGFR is exceedingly rich in SS bridges and aromatic residues [28] . In Figure 2 is displayed the crystal structure of the complex formed between human EGF and the extracellular domain of human EGFR [3] . The extracellular domain of human EGFR comprises 25 disulphide bridges, 6 Trp, 16 Tyr and 18 Phe per chain. As mentioned before, UV excitation of aromatic residues leads to the disruption of disulphide bridges in proteins. Therefore, it is likely that conformation changes are induced in the 3D structure of EGFR upon UV excitation of its aromatic pool, provided that the UV light irradiance (power per unit area) is above a certain threshold. Such conformational changes are likely to inhibit its function and prevent the correct binding to its ligands .
We have previously shown that laser pulsed UV treatment of two skin-derived tumor cell lines leads to the inhibition of the EGF receptor and key downstream molecules such as AKT1 and ERK1/2 involved in the RTK-catalyzed signaling cascade [13] . Our previous results show a potential for treatment of skin diseases associated with increased proliferation relating to the EGF receptor e.g. warts, condylomas, psoriasis and skin cancer. This technology can be applicable to the treatment of various forms of cancer, and can be used in combination with the classical photodynamic therapy and other cancer therapies to improve treatment outcome.
Our present goal is to gain insight on the effects of UV-light on the structure of the extracellular domain of EGFR that could explain the loss of EGFR phosphorylation in the presence of EGF previously observed when cancer cell lines overexpressing EGFR were illuminated with 280 nm UV light [13] . The new results will help us understanding why the (15) new photonic cancer therapy works. We hereby report structural changes induced by UV light on the extracellular domain of EGFR. Steady state fluorescence spectroscopy and binding immunoassays are reported. Figure 2 . Crystal structure of a 1:1 complex between human EGF and EGFR extracellular domain (1ivo.pdb) [3] . The disulphide bridges and aromatic residues atoms are displayed as CPK: SS bridges in yellow, Trp in green, Tyr in dark blue and Phe in cyan; 18 out of 25 SS bridges, 5 out of 6 Trp residues, 13 out of 16 Tyr residues and 17 out of 18 Phe residues are displayed since some residues are missing in the pdb file. EGF is displayed in red.
MATERIAL AND METHODS

Protein and Buffer Solutions
Recombinant human EGFR protein from Speed Biosystems (YCP1031), made in human embryonic kidney (HEK) 293 cells, with amino acid sequence corresponding to the extracellular domain of EGFR (Leu25-Ser645) and a C-terminal polyhistidine (His) tag was used.
Stock solution of extracellular EGFR was prepared by dissolving the powder in 10 mM Sodium Phosphate Buffer (NaPB) pH 7.5 to a concentration of 3.9 µM. The concentration of extracellular EGFR in solution was determined by Abs 280 nm using a molar extinction coefficient of 60,000 M -1 cm -1 (calculated using the tool ProtParam, ExPASy; [29] . Milli-Q water with conductivity below 0.2 μS.cm -1 was used. Stock solution was kept desiccated and protected from light at -20°C until use.
3D protein structure
The crystallography data used for 3D protein structure display ( Figure 2 ) was retrieved from the PDB file 1IVO (crystal structure of the complex of human epidermal growth factor and receptor extracellular domains) [3] . The 3D structure was displayed using Accelrys Discovery Studio Visualizer 3.5. The disulphide bridges and aromatic residues atoms were displayed with standard Corey-Pauling-Koltun (CPK) values.
UV illumination of the extracellular domain of human EGFR
For each experiment, 100 µl of a 3.9 µM of extracellular EGFR stock solution was placed in a quartz cuvette (2mm x 10mm x 6mm excitation volume) and UV illuminated with 280 nm light for 75 min (10mm path length) at 20°C (+/-0.5°C). The quartz cuvette was placed in a dark box with the UV-transparent quartz cuvette facing towards the exit slit opening of a ChronosBH spectrometer (ISS) monochromator connected to a 300W Xenon Arc lamp source (radiant power 89 ± 10 µW). The excitation slits were always set to 4 nm. A 3.9 µM sample of extracellular EGFR stock solution was kept in the same conditions but without UV illumination and used as a negative control (NC).
Fluorescence Studies
Fluorescence measurements were carried out using a ChronosBH (ISS) spectrometer. Samples were illuminated through a 10 mm path length window, and fluorescence collected from the 2 mm path length window. The excitation and emission slits were set to 4 nm and 8 nm, respectively, for all fluorescence measurements.
. Fluorescence emission kinetic trace
Fluorescence emission intensity at 350 nm was recorded every 1 sec during the 75 min of UV illumination for the UV illuminated human extracellular EGFR sample.
. Emission spectra
Emission spectra were recorded for the non-illuminated, UV illuminated for 75 min and negative control human extracellular EGFR samples. Emission spectra were acquired with 280 nm and 295 nm excitation. Solution temperature was set at 20°C (+/-0.5°C) using a Peltier element at the cuvette holder location.
. Melting curve
A melting curve was recorded for the non-illuminated and UV illuminated for 75 min human extracellular EGFR sample with exictation set at 295 nm and emission at 330 nm. Temperature was increased from 4°C to 90ºC (+/-0.5°C) using a Peltier element at the cuvette holder location. After reaching 90ºC, the sample was cooled to 4ºC. Heating and cooling rates were set to 1ºC/min.
Human extracellular EGFR binding immunoassay
A binding immunoassay was used to analyze the effects of UV illimination on the binding site of EGF to EGFR. More specifically, the primary mouse monoclonal antibody anti-EGFR neutralizer antibody LA1 from Milipore (05-101), which competes with EGF and TGF-α for binding EGFR [30] was used.
For each experiment, 1.4 µg of non-illuminated, UV illuminated for 75 min and negative control sample protein were analyzed by Western blot. Samples were resolved by reduced sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), 7.5 % polyacrylamide from Bio-Rad (4561023), transferred to a 0.2 µm nitrocellulose membrane from Whatman (10402495). Then, the membrane was probed with 1:1000 of LA1 primary antibody followed by incubation with 1:5000 of goat anti-mouse horseradish peroxidase (HRP)-conjugated secondary antibody from Santa Cruz Biotech (SC-2005). Immune complexes were visualized on nitrocellulose by enzyme-linked enhanced chemiluminescence (ECL) from GE Healthcare (RPN2232) and detected using the CCD camera of G:Box chemi XT4 controlled by Genesys software from Syngene. Band intensities were quantified using gel analysis software GeneTools from Syngene.
RESULTS AND DISCUSSION
The prevailing model for the activation of human EGFR supports that the binding of the ligands, such as EGF, to the extracellular domain of the protein is responsible for the dimerization of the protein and consequent activation of its kinase activity. Not surprisingly, EGF-EGFR signaling axis has taken the center stage of cancer research, and many EGFR-targeted agents were developed that inhibit EGFR activity by preventing ligand-binding [10] [11] [12] . Nonetheless, other inhibition approaches have also been developed against the tyrosine kinase domain [8, 9] , which are particularly important in mutants lacking part of the extracellular domain and where EGFR is activated independently of ligand binding.
Our present goal was to gain insight on the effects of UV light at the protein structure level that could explain the loss of EGFR phosphorylation previously observed in two cancer cell lines overexpressing EGFR illuminated with 280 nm UV light, even in the presence of EGF [13] . In order to evaluate these effects on the extracellular domain of EGFR, we have used a recombinant human protein with amino acid sequence Leu25-Ser645, corresponding to the extracellular domain of EGFR only.
Fluorescence emission kinetic trace (excitation 280 nm)
In order to study the effects of UV excitation on the fluorescence properties of the extracellular domain of EGFR, the protein solution was illuminated for 75 min at 280 nm (radiant power 89 ± 10 µW) The fluorescence emission intensity spectra at 350 nm was recorded and the kinetics is displayed in Figure 3 .
The fluorescence emission spectra at 350 nm during the 75 min UV illumination of human extracellular EGFR sample is shown in Figure 3 . Fitting of the kinetic trace shows that the fluorescence emission intensity at 350 nm decreases biexponentially with UV illumination time. We can observe in the first 17 min a very rapid decrease in the number of counts per second, followed by a slower decrease of the fluorescence counts. After 75 min of continuous UV excitation the fluorescence emission intensity has dropped to 33.8% of its initial intensity value. The parameter values obtained upon fitting the EGFR fluorescence emission kinetic trace recorded with emission fixed at 350 nm (exc. 280 nm) are displayed in Table 1 . A double exponential model has been used to fit the decay. Data reveals that prolonged UV excitation of the protein molecules leads to photochemical reactions involving Tyr and Trp residues, according to the schemes 1-8 mentioned in the introduction. The new formed species have a considerable lower fluorescence emission at 350 nm when compared to the fluorescence emission of the non illuminated sample. A B assigned to Trp residues since 295 nm light will selectively excite Trp residues. Normalization of the emission spectra ( Figure 5B ) shows that the wavelength at maximum fluorescence emission intensity has been red-shifted by 6 nm after prolonged UV excitation. This observation indicates that UV excitation of the protein leads to conformational changes that rendered the Trp pool of the protein more solvent accessible. An increase in the normalized fluorescence emission intensity at wavelengths above 380 nm is observed.
Figurte 5. Fluorescence emission spectra of human extracellular EGFR upon 295 nm excitation. Emission spectra were recorded for non illuminated (non illum) and UV illuminated for 75 min (illum for 75 min) human extracellular EGFR samples. (A) Emission spectra. (B) Corresponding normalized emission spectra.
Protein thermal stability
Protein conformational changes induced by UV excitation of the extracellular domain of human EGFR were further investigated by temperature dependent fluorescence spectroscopy studies. The melting temperature of non illuminated human extracellular EGFR sample was compared with the melting temperature of the protein after being illuminated at 280 nm for 75 min. The temperature dependence of the protein fluorescence emission at 330 nm upon 295 nm excitation for non illuminated sample is displayed in Figure 6 .
The parameter values obtained upon curve fitting are displayed in Table 2 . A modified Boltzmann model has been used to fit the decay. The initial drop in fluorescence emission intensity from 4 to 60 ºC is due to collisional quenching by the solvent molecules induced by the temperature increase. Data reveals that a transition is observed approximately from 60ºC to 72ºC for the non illuminated protein sample (transition midt-point at 69.72 ± 0.24ºC) while no transition is observed for the previously excited sample in that temperature interval with 280 nm light for 75 min. Furthermore, it can be observed that the thermal unfolding of the protein is irreversible since no transition is observed on the cooling trace (data not shown). The lower and top limits of the Boltzmann function were defined using the linear functions A 1 +B 1 .x and A 2 +B 2 .x, respectivelly.
A B
A 1 : intercept for the lower limit; B 1 : slope for the lower limit; A 2 : intercept for the top limit; B 1 : slope for the top limit; x 0 : inflexion point; dx: width
EGFR binding immunoassay
The primary mouse monoclonal antibody anti-EGFR neutralizer antibody LA1 from Milipore (05-101) has been described as competing with EGF and TGF-α for EGFR binding [30] (see EGF-EGFR complex shown in Figure 2 ). Furthermore, LA1 anti-EGFR inhibits growth, induces differentiation to a more epithelial phenotype, reduces the constitutive activation of EGFR, and up-regulates epithelial cadherin glycoprotein expression in human lung cancer cell line H322 and normal human bronchial epithelial NHBE cells. In contrast, LA1 has no effect on either growth, differentiation, receptor tyrosine phosphorylation, or the expression of adhesion molecules in human lung cancer cell line H661 cells, a cell line does not express detectable levels of EGFR [31] . Hence, a binding immunoassay using LA1 anti-EGFR was used to indirectly access the effects of UV illumination on the structure of the EGFR binding site to EGF and TGF-α. Using non-illuminated, UV illuminated and negative control protein, our results showed that UV illumination prevents the binding of LA1 anti-EGFR to UV illuminated sample, as observed by the almost complete disappearance of the band corresponding to human extracellular EGFR in these samples (illum for 75 min) (Figure 7 ). On the contrary, LA1 anti-EGFR was able to detect the protein in non illuminated and negative control samples, with approximately the same binding affinity (Figure7). This demonstrates that UV light prevented the binding ot the EGF/TGF-α binding competitor anti-EGFR LA1 to the extracellular domain of human EGFR. In order to establish a correlation between the band intensities and the efficiency of antibody binding, exactly the same amount of protein was loaded into each well. Two sets of duplicate samples were used to demonstrate the accuracy of the method.
Further studies are still needed to directly access the effects of UV light on EGFR binding sites to its ligands, such as EGF and TGF-α. However, these results supported that the UV illumination affects the structure of the extracellular domain of human EGFR. Such changes are also likely to prevent the correct binding of EGF to EGFR. Figure 7 . UV illumination of extracellular EGFR prevents binding of anti-EGFR neutralizer antibody LA1 to its target antigen. In each well, exactly 1.4 µg of non illuminated (non illuminated; 1 and 4), UV illuminated for 75 min (illum for 75 min; 2 and 5) and negative control (NC; 3 and 6) human extracellular EGFR samples was loaded. Samples loaded on well 1-3 are duplicates of samples 4-6, but were treated independently after UV illumination. In the graph are displayed the mean value ± s.e.m. of the band intensities obtained for the 2 sets of samples.
CONCLUSION
In this paper, we report the effects of 280 nm UV-light on the structure of the extracellular domain of EGFR. Steady state fluorescence spectroscopy and binding immunoassays were done in order to report structural changes induced by UV light on the extracellular domain of EGFR. The results obtained may explain the loss of EGFR phosphorylation in the presence of EGF previously observed when cancer cell lines overexpressing EGFR were illuminated with 280 nm UV light (Olsen et al., 2007) , although further studies are also needed to evaluate the effects of UV light on EGFR intrinsic kinase activity. Although further research, we believe that this study is a starting point to undercover how and why this approach may work as a future anti-cancer strategy, alone or in combination with other therapies. 
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